Cargando…
The nonlinear relationship between cerebrospinal fluid Aβ(42) and tau in preclinical Alzheimer’s disease
Cerebrospinal fluid (CSF) studies consistently show that CSF levels of amyloid-beta 1–42 (Aβ(42)) are reduced and tau levels increased prior to the onset of cognitive decline related to Alzheimer’s disease (AD). However, the preclinical prediction accuracy for low CSF Aβ(42) levels, a surrogate for...
Autores principales: | de Leon, Mony J., Pirraglia, Elizabeth, Osorio, Ricardo S., Glodzik, Lidia, Saint-Louis, Les, Kim, Hee-Jin, Fortea, Juan, Fossati, Silvia, Laska, Eugene, Siegel, Carole, Butler, Tracy, Li, Yi, Rusinek, Henry, Zetterberg, Henrik, Blennow, Kaj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802432/ https://www.ncbi.nlm.nih.gov/pubmed/29415068 http://dx.doi.org/10.1371/journal.pone.0191240 |
Ejemplares similares
-
Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
por: Fossati, Silvia, et al.
Publicado: (2019) -
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
por: Lautner, Ronald, et al.
Publicado: (2017) -
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
por: Delaby, Constance, et al.
Publicado: (2022) -
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2016) -
Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)